


On 24 February 2017, Dr. Hemant Mardia, primary insider and CEO of IDEX,
exercised 5,000,000 subscription rights that were granted to him under the
company's 2013 incentive subscription rights plan and acquired the corresponding
number of shares at a weighted average price of NOK 1.69 per share. To fund the
exercise and tax amounts, Dr. Mardia sold 3,250,000 shares at a price of NOK
6.00 per share on the same day. Following these transactions, Dr. Mardia and his
close associates hold or control 2,115,625 shares and 3,250,000 subscription
rights in IDEX.

On 24 February 2017, Fred Benkley, primary insider and CTO of IDEX, was granted
750,000 subscription rights under the company's 2016 incentive subscription
rights plan. The exercise price of the subscription rights is NOK 6.59 per
share. 25 % of the subscription rights vest on each anniversary from the date of
the grant. The subscription rights expire on 11 May 2021. In addition, the Board
resolved to extend the duration of 500,000 subscription rights granted to Mr.
Benkley in 2013, from 23 September 2017 until 16 May 2018. Following these
transactions, Mr. Benkley and close associates hold or control 0 (nil) shares
and 1,600,000 subscription rights in IDEX.

24 February 2017
IDEX ASA

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.


 
    